15.01.2015 Views

CST Guide:

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Section I: Research Areas<br />

Molecular rendering of<br />

tumor vascularization<br />

Angiogenesis<br />

Angiogenesis is the formation of new blood vessels from pre-existing larger blood vessels. It is required<br />

during embryogenesis, and defects in or interference with this process have severe consequences<br />

for embryonic development. In adult organisms, angiogenesis plays a key role in normal physiological<br />

processes such as wound healing and inflammation, and in mammalian placental development.<br />

The process of angiogenesis can also be hijacked by tumors, which require a supply of oxygen and<br />

nutrients to support the high metabolic rate of tumor cells.<br />

VEGF Receptor Signaling<br />

Vascular endothelial growth factor receptors (VEGFR) are a receptor tyrosine kinase family composed of<br />

seven extracellular immunoglobulin (Ig)-like domains, a transmembrane region, and a cytoplasmic tail<br />

containing an active kinase domain. VEGFR1 plays an important role in EC function and normal vascular<br />

development, as well as in hematopoietic function. VEGFR2 is a major receptor for VEGF-induced signaling<br />

in endothelial cells. Upon ligand binding, VEGFR2 undergoes autophosphorylation and becomes<br />

activated. Signaling from VEGFR2 is necessary for the execution of VEGF-stimulated proliferation,<br />

chemotaxis, and sprouting, as well as survival of cultured ECs in vitro and in vivo. VEGFR3 expression is<br />

largely restricted to adult lymphatic endothelium and is thought to control lymphangiogenesis.<br />

VEGFR phosphorylation<br />

at tyrosine residues<br />

activates downstream<br />

signaling cascades that<br />

support angiogenesis.<br />

Tyr801<br />

Tyr951<br />

Tyr966<br />

Tyr1008<br />

Tyr1054<br />

Tyr1059<br />

Tyr1175<br />

Tyr1214<br />

VEGF<br />

lg-like<br />

domains<br />

P<br />

Akt<br />

P TSAd<br />

P<br />

P PLCγ<br />

P<br />

Cbl<br />

P<br />

P PLCγ Cbl<br />

P Shb<br />

P Grb2 Gab1<br />

SHP2<br />

Src<br />

PI3K<br />

PLCγ<br />

PI3K<br />

Src<br />

chapter 06: Development and differentiation<br />

Vascular permeability,<br />

cell migration<br />

Endothelial cell migration<br />

Differentiation, tubulogenesis<br />

Cell proliferation, angiogenesis<br />

Focal adhesion formation,<br />

cell migration<br />

Cell migration, lamellipodia<br />

formation, capillary formation<br />

Kinase domain<br />

Autophosphorylation<br />

Angiogenesis Signaling<br />

When angiogenesis is stimulated, pro-angiogenic growth factors such as VEGF, PDGF, FGF, and TGF<br />

are released. These growth factors bind their cognate receptors on endothelial cells (EC) within preexisting<br />

vessels. This triggers a signaling cascade that activates several signaling pathways such as<br />

PI3K/Akt, Erk1/2, Smad, and Notch and results in EC proliferation and migration. New blood vessel<br />

formation occurs as ECs use matrix metalloproteases (MMPs) and integrins to digest extracellular<br />

matrix and migrate into new territory where they lengthen and form tubes.<br />

VEGF treatment results in phosphorylation<br />

of VEGFR-2 at Tyr1175.<br />

PathScan ® Phospho-VEGFR-2 (Tyr1175) Sandwich ELISA Kit #7335:<br />

Treatment of HUVEC with VEGF stimulates phosphorylation of VEGFR-2 at<br />

Tyr1175, detected by #7335, but does not affect the level of total VEGFR-2<br />

protein detected by PathScan ® Total VEGFR-2 Sandwich ELISA kit #7340.<br />

Absorbance at 450 nm is shown in the top figure, while the corresponding<br />

western blot using Phospho-VEGFR-2 (Tyr1175) Rabbit mAb #2478 (right<br />

panel) or VEGFR-2 Rabbit mAb (7340-55B11) (left panel), is shown in the<br />

bottom figure.<br />

Untreated<br />

VEGF-treated<br />

Absorbance 450nm<br />

3.5<br />

3.0<br />

2.5<br />

2.0<br />

1.5<br />

1.0<br />

0.5<br />

0<br />

kDa<br />

200<br />

140<br />

Total VEGFR-2<br />

Phospho-VEGFR-2<br />

(Tyr1175)<br />

– + – + VEGF<br />

TPA induces expression of MMP-9, a protease that digests<br />

extracellular matrix and is associated with tumor angiogenesis.<br />

MMP-9 (D6O3H) XP ® Rabbit mAb #13667:<br />

IHC analysis of paraffin-embedded human breast<br />

carcinoma (A) using #13667. WB analysis of<br />

concentrated, serum-free cultured medium from<br />

U-2 OS cells, untreated (-) or treated with TPA<br />

#4174 (200 nM, 48 hr; +) (B), using #13667.<br />

A<br />

B<br />

kDa<br />

200<br />

140<br />

100<br />

80<br />

60<br />

50<br />

40<br />

30<br />

– +<br />

MMP-9<br />

TPA<br />

Neuropilin-2<br />

In addition to neuronal guidance, the single pass, transmembrane glycoprotein neuropilin-2<br />

is a co-receptor for VEGFR2 and VEGFR3, and plays a role in the development of vascular<br />

and lymphatic systems through binding VEGF 165 and VEGF145.<br />

Neuropilin-2 is expressed in the<br />

developing mouse embryo.<br />

Neuropilin-2 (D39A5) XP ® Rabbit mAb #3366: Confocal<br />

IF analysis of E14.5 mouse embryo using #3366 (green).<br />

Blue pseudocolor = DRAQ5 ® #4084 (fluorescent DNA dye).<br />

<strong>CST</strong> Technical<br />

Support<br />

When you contact <strong>CST</strong> for technical<br />

support, you can be confident you<br />

will be working with a colleague<br />

you can trust, striving to provide the<br />

highest quality products and services<br />

to you, our customer. Please see our<br />

Technical Support resource page<br />

online for contact information.<br />

www.cellsignal.com/cstsupport<br />

166 For Research Use Only. Not For Use in Diagnostic Procedures. See pages 302 & 303 for Pathway Diagrams, Application, and Reactivity keys.<br />

www.cellsignal.com/cstangiogenesis<br />

167

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!